Growing evidence has shown that colchicine inhibits NLRP3 inflammasome activation (Demidowich et al., 2016) and effectively reduces the overall mortality of COVID-19 patients (Reyes et al., 2020). The gene discussed is NLRP3; the disease is COVID-19.